•
Dec 31, 2021

Immuneering Q4 2021 Earnings Report

Total Revenue
$190K
Previous year: $665K
-71.5%
EPS
-$0.42
Previous year: -$1.18
-64.4%
Gross Profit
-$16.6K
Previous year: $192K
-108.7%
Cash and Equivalents
$74.9M
Previous year: $37.1M
+101.9%
Free Cash Flow
-$9.25M
Previous year: -$5.49M
+68.5%
Total Assets
$167M
Previous year: $38.4M
+333.9%

Immuneering

Immuneering